Recent Analysts’ Ratings Updates for Strata Critical Medical (SRTA)

A number of research firms have changed their ratings and price targets for Strata Critical Medical (NASDAQ: SRTA):

• 3/26/2026 – Strata Critical Medical was upgraded by Zacks Research to “hold”.
• 3/25/2026 – Strata Critical Medical is now covered by Craig Hallum. They set a “buy” rating and a $8.00 price target on the stock.
• 3/25/2026 – Strata Critical Medical is now covered by B. Riley Financial, Inc.. They set a “buy” rating and a $8.00 price target on the stock.
• 3/24/2026 – Strata Critical Medical is now covered by Weiss Ratings. They set a “hold (c-)” rating on the stock.
• 3/24/2026 – Strata Critical Medical was upgraded by B. Riley Financial, Inc. to “strong-buy”.

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.